| collagen, type I, alpha 2 |
COL1A2 |
161.55 |
| lumican |
LUM |
82.13 |
| collagen, type I, alpha 1 |
COL1A1 |
67.11 |
| periostin, osteoblast specific factor |
POSTN |
43.08 |
| fibrillin 1 (Marfan syndrome) |
FBN1 |
30.94 |
| gremlin 1 homolog, cysteine knot superfamily (Xenopus laevis) |
GREM1 |
30.83 |
| collagen, type VI, alpha 3 |
COL6A3 |
30.28 |
| platelet-derived growth factor receptor, beta polypeptide |
PDGFRB |
22.38 |
| gap junction protein, alpha 1, 43kDa (connexin 43) |
GJA1 |
21.12 |
| collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) |
COL3A1 |
17.78 |
| ABI gene family, member 3 (NESH) binding protein |
ABI3BP |
13.92 |
| transgelin |
TAGLN |
5.61 |
| chromosome 5 open reading frame 13 |
C5orf13 |
5.30 |
| chondroitin sulfate proteoglycan 2 (versican) |
CSPG2 |
4.38 |
| serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
SERPINE2 |
4.26 |
| angiopoietin-like 4 |
ANGPTL4 |
4.06 |
| lysyl oxidase |
LOX |
3.67 |
| collagen, type V, alpha 2 |
COL5A2 |
3.25 |
| nicotinamide N-methyltransferase |
NNMT |
2.76 |
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
PTGS1 |
2.47 |
| heterogeneous nuclear ribonucleoprotein A1 |
HNRNPA1 |
2.41 |
| cadherin 11, type 2, OB-cadherin (osteoblast) |
CDH11 |
2.33 |
| actinin, alpha 4 |
ACTN4 |
2.1 |
